Previous Article | Next Article 
Applied and Environmental Microbiology, October 2003, p. 5787-5792, Vol. 69, No. 10
0099-2240/03/$08.00+0 DOI: 10.1128/AEM.69.10.5787-5792.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Development of an Improved Selective Agar Medium for Isolation of Yersinia pestis
Raphael Ber, Emanuelle Mamroud, Moshe Aftalion, Avital Tidhar, David Gur, Yehuda Flashner, and Sara Cohen*
Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 74100, Israel
Received 14 March 2003/
Accepted 9 July 2003

ABSTRACT
Existing media designed for selective isolation of clinically
important members of the genus
Yersinia were found to be unsatisfactory
for the growth and isolation of
Yersinia pestis. We report the
development of a new selective agar medium (termed BIN) that
supports the growth of
Y. pestis. The development of the formulation
of this medium was based on a fluorescence screening system
designed for monitoring bacterial growth on semisolid media,
using a green fluorescent protein-expressing strain. High-throughput
combinatorial experiments can be conducted for the quantitative
evaluation of the effect of different medium components on growth.
Generation of fluorescence plots in this system, using microplates,
allowed the quantitative evaluation of the growth rate of
Y. pestis EV76 cultures in different agar compositions. The final
BIN formulation is based on brain heart infusion agar, to which
the selective agents irgasan, cholate salts, crystal violet,
and nystatin were introduced. It was found that BIN agar is
more efficient in supporting colony formation and recovery of
Y. pestis than are the conventional semisolid media MacConkey
agar and
Yersinia-selective agar (cefsulodin-irgasan-novobiocin
agar). The advantage of BIN over other media has been also demonstrated
in recovering virulent
Y. pestis from the mixed bacterial populations
found in decaying carcasses of infected mice. The BIN medium
is suggested as a selective medium for isolation and recovery
of
Y. pestis from various backgrounds.

INTRODUCTION
Plague, caused by the bacterial pathogen
Yersinia pestis, is
one of the oldest recorded infectious diseases and in the past
has claimed millions of lives (
6,
20,
21). Natural foci of plague
are still spread worldwide, mainly in the rodent and flea vector
reservoirs (
26,
27). Periodic epizootics, climate changes, rodent
population size and migration, and landscape modifications affect
the dynamics of most plague focus outspreads. Most human plague
cases in recent years occurred among individuals who were in
contact with wild rodents in areas of endemicity (
6), but occasionally
infections were reported in areas where
Y. pestis infected domestic
carriers such as rats, cats, and several other mammalian species
(
7,
12). The thousands of cases reported yearly to the World
Health Organization (WHO) in the last decade indicate that plague
is far from being eradicated and continues to present a threat,
especially where public health and living conditions are poor
(
26). Future global pandemics are improbable; however, the potential
use of
Y. pestis as a biological weapon could cause pneumonic
plague in large populations (
14).
The course of clinical infection is often characterized by fast progression in vivo, and death occurs rapidly if proper antibiotic treatment is not applied within 18 to 24 h of disease onset (4, 5, 21). Unlike most Enterobacteriaceae, all known Y. pestis strains exhibit slow growth in vitro on conventional laboratory media (3, 23). Thus, development of a medium that would facilitate rapid yet specific isolation of Y. pestis may have an important impact on both clinical diagnosis and plague surveillance.
Current WHO regulations for isolation of Y. pestis recommend the use of brain heart infusion agar (BHIA), sheep blood agar, and MacConkey agar (10). These growth media are best suited for isolation of the bacteria from clinical samples that are otherwise usually sterile (such as blood, lymph node, bubo aspirates, and cerebrospinal fluid), so that the infectious agent is expected to grow as a pure culture. However, when the clinical form of disease requires the use of nonsterile samples such as sputum, respiratory tract swabs or washings, skin swabs, or skin scrapings, the isolation of Y. pestis may be complicated by the presence of background flora competing for nutrients and resources of the medium (especially on the nonselective rich media), due to both higher growth rates and possibly higher initial numbers. This problem becomes more pronounced when environmental samples or decomposing carcasses of infected animals are tested for the presence of Y. pestis (16).
Among the media recommended by the WHO for Y. pestis isolation, only MacConkey agar possesses a certain degree of selectivity, mainly due to the presence of crystal violet (which inhibits gram-positive organisms) and bile salts (which inhibit growth of nonenteric bacteria). However, since MacConkey medium was originally developed for isolation of enteric bacteria in general, it allows growth of a large number of gram-negative organisms. Moreover, the slow growth exhibited by Y. pestis on this medium restricts its applicability as a selective medium for mixed cultures. Few attempts have been made in the past to develop selective and/or differential media for Y. pestis (11, 17, 18, 19, 25). More recently, cefsulodin-irgasan-novobiocin (CIN) agar, developed primarily for isolation of Yersinia enterocolitica (24), has been proposed as an alternative selective medium for Y. pestis (22). Although Y. pestis can generally tolerate the levels of selective substances used in CIN agar, only a portion of the plated bacteria grow to form colonies (1, 23). It thus appears that the formulations of selective agents at the levels used in CIN and MacConkey agars cause a decrease in growth rate that results in a lower recovery of Y. pestis.
In the present report, we document the formulation of a novel improved medium that has the high selectivity required for isolation of Y. pestis from a variety of sources. Furthermore, the new medium enables a significantly improved recovery of Y. pestis compared to the presently available selective media.

MATERIALS AND METHODS
Media.
Luria-Bertani broth, BHIA, CIN medium, and MacConkey agar (all
from Difco) were prepared according to instructions of the manufacturer
(Difco manual, 11th ed., 1998). The individual components of
CIN medium used for preparation of basal CIN medium (growth-supportive
components of CIN medium without the selective agents [see Table
2]) were from Difco, except for
D-mannitol (Sigma) and sodium
chloride (Merck). Blood agar plates supplemented with 5% defibrinated
sheep blood were purchased from a local supplier (Hy-Laboratories).
Stock solutions used for the formulation of different medium
combinations were prepared as follows. Irgasan DP300 (Ciba-Geigy)
solution was made at 0.2 mg/ml in 90% ethanol and was added
aseptically to autoclaved media after cooling to about 80 to
85°C, followed by vigorous shaking to volatilize the ethanol.
Crystal violet stock solution was prepared at 1 mg/ml in double-distilled
water (ddH
2O) and autoclaved. Sodium cholate and sodium deoxycholate
(both from Sigma) were prepared by dissolving 5 g each in 100
ml of ddH
2O and autoclaved. Nystatin (Sigma) (10
5 U/ml) was
prepared in ddH
2O and vigorously mixed by vortexing before use.
Cefsulodin (1.5 mg/ml) and novobiocin (1.5 mg/ml) solutions
(both from Sigma) were stored at -70°C and thawed just before
use. All media were poured either at 25-ml volumes in standard
petri dishes or at 1-ml volumes in 24-well (flat-bottom) tissue
culture plates (Techmo Plastic Products).
Bacterial strains.
Yersinia strains included the virulent
Y. pestis Kimberley53
(
2,
13); the nonvirulent
Y. pestis TRU, A1122, and EV76 (
2);
and the enteric
Y. enterocolitica WA (ATCC 27729),
Y. enterocolitica CDC 497-70 (ATCC 29913), and
Yersinia pseudotuberculosis III
and 134 C strains (
2). Other gram-negative strains used in selectivity
studies were
Escherichia coli ATCC 25922 and ATCC 35218,
Pseudomonas aeruginosa ATCC 27853,
Enterococcus faecalis ATCC 29212 and
ATCC 51299, and local isolates of
Salmonella enterica serovar
Typhimurium,
Vibrio cholerae,
Shigella dysenteriae, and
Serratia marcescens. Gram-positive strains used were
Staphylococcus aureus ATCC 25923 and ATCC 29213,
Bacillus cereus ATCC 10987 and ATCC
14579,
Bacillus thuringiensis subsp.
israelensis ATCC 35646,
Bacillus amyloliquefaciens 10A1 (Bacillus Genetic Stock Center),
Bacillus subtilis WB600 (
28), and
Bacillus anthracis 
14185 (
8).
The strains were kept frozen at -70°C. For each experiment,
bacteria were plated for isolation on BHIA and incubated for
1 day at 28°C for the enteric
Yersinia strains, for 2 days
at 28°C for
Y. pestis strains, or for 1 day at 37°C
for all other strains. Comparative studies with different medium
formulations were conducted at 28°C. Plates were examined
after 24, 36, and 48 h of incubation (and in some cases after
up to 4 days) for CFU counts, colony size, and color.
Plating efficiency tests.
The ability of different media to support the growth and recovery of Y. pestis was determined by the efficiency of colony formation. Bacterial suspensions from fresh colonies grown on BHIA were adjusted in sterile phosphate-buffered saline (PBS) to optical density at 660 nm (OD660) of 0.2 (ca. 1 x 108 to 3 x 108 CFU/ml). The bacterial suspensions were serially diluted 10-fold, and 0.1-ml aliquots of each dilution were plated on at least triplicate plates of the tested media. The recovery percentage was calculated from the ratio of the mean counts of colonies on the test medium and on nonselective BHIA as a reference. The size of colonies at a given incubation period was also used to evaluate the effect of selective substances on growth.
Construction of Y. pestis strain EV76 expressing GFP.
The pGFPuv plasmid (Clontech Laboratories Inc.) was electroporated into competent EV76 cells essentially as described by Conchas and Carniel (9). In short, cells were cultured in Luria-Bertani medium (to an OD660 of 0.7), washed twice in cold ddH2O, and concentrated to 4 x 109 CFU/ml in transformation buffer (15% glycerol, 0.27 M sucrose), and 0.1 ml was electroporated with 250 ng of plasmid DNA. The transformation efficiency was 5.5 x 105 CFU/µg. Colonies expressing GFP were clearly visible by UV illumination. Several clones were picked at random, and the presence of the three Y. pestis virulence plasmids was confirmed. The fluorescence levels (excitation wavelength, 410 nm; emission wavelength, 510 nm) emitted by bacterial suspensions of the derivative strain EV76(pGFPuv) were found to correlate directly with the CFU counts. Other growth characteristics of these clones were not different from those of the progenitor strain. The pGFPuv plasmid was found to be very stable in Y. pestis even after many passages without antibiotic selection.
Evaluation of growth rate on semisolid media.
The effect on growth of the supportive and/or selective substances that were incorporated into different agar formulations was evaluated by using the GFP-expressing EV76 strain. For this purpose, a bacterial suspension in PBS (OD660 of 0.02) was spread in aliquots of 0.03 ml on the surface of the tested medium, which was previously prepared in a 24-well microplate (3 x 105 to 1 x 106 CFU/well). The microplates were incubated in a spectrofluorimeter (SPECTRAFluor Plus; Tecan) at 28°C, and the fluorescence emitted by the bacteria was determined hourly. For each culture, relative fluorescence units were plotted against incubation time, using the fluorescence values at the beginning of the incubation as background. At least six replicates were tested for each medium combination.
Selectivity tests.
Tested strains were isolated on BHIA, and several fresh colonies were used to prepare suspensions containing
108 CFU/ml in PBS. These suspensions were serially diluted 10-fold, and aliquots of 10 µl from each dilution were placed on BHIA, BIN agar, MacConkey agar, and CIN agar. Isolation of different strains on the tested media was conducted with standard 1-µl bacterial loops from concentrated colony suspensions (>109 CFU/ml). Selectivity tests were conducted at 28°C and monitored daily for 3 days.
Recovery from infected mice.
Female mice (6 weeks old, OF1 outbred; purchased from Charles River Laboratories, Saint Aubin les Elbeuf, France) were inoculated subcutaneously with 100 50% lethal doses (LD50) of the virulent Y. pestis Kimberley53 strain (1 LD50 = 1 CFU). Dead mice were kept separately at room temperature, and after 3, 5, 8, and 11 days their spleens and livers were homogenized separately in 2 ml of PBS. Samples were prepared from at least five corpses at each time point. Each sample was streaked for isolation and was also serially diluted 10-fold in PBS for comparative Y. pestis isolation and recovery efficiency tests on several semisolid media (BHIA, BIN agar, CIN agar, MacConkey agar, and blood agar). The plates were incubated at 28°C for up to 3 days, and growth was recorded daily for CFU counts, colony size, and color. Colonies isolated from BIN and CIN media were further verified as Y. pestis by immunofluorescence staining with polyclonal rabbit anti-F1 antibodies, as previously described (13). These experiments were conducted in compliance with Israeli law and the Israel Institute for Biological Research ethical policies for use of experimental animals.

RESULTS AND DISCUSSION
Growth of Y. pestis on commercial selective semisolid media.
The problematic growth of
Y. pestis compared to that of
Y. enterocolitica is exemplified on the commercially available selective media
MacConkey agar and CIN agar and the nonselective medium basal
CIN agar (containing only the growth-supportive components of
CIN agar) and BHIA (Table
1). As expected,
Y. enterocolitica demonstrated high recoverability on the tested media. However,
Y. pestis strain EV76 yielded high recovery levels and homogeneous
colonies (in terms of size range) only on the nonselective media,
while plating on the selective media resulted in reduced growth.
Colonies of EV76 grown on MacConkey agar exhibited a wide range
of sizes, with all of the colonies being smaller than those
developing in the enriched media. The percentages of recovery
of EV76 (Table
1) were dependent on the incubation period, and
higher values (90 to 100%) were obtained after prolonged incubation
for up to 4 days (data not shown). CIN medium was found to be
more restrictive than MacConkey agar for the growth of
Y. pestis.
Only 5% of the bacteria were recovered after 36 h, and the colonies
were in a wide range of sizes. CFU counts were consistently
lower by about 1 order of magnitude than those on the nonselective
media, and they did not increase upon prolonged incubation.
Our results are in agreement with the quantitatively reduced
growth of
Y. pestis on CIN agar reported previously by Russell
et al. (
23). The differences in growth between the nonselective
and selective media may be attributed to a lack of proper growth-supportive
nutrients and/or to the presence of inhibitory substances or
selective agents in MacConkey and CIN agars that restrict the
growth of
Y. pestis.
Formulation of a new selective medium for Y. pestis.
For the evaluation of the effect of medium components on growth
of
Y. pestis, we monitored the growth on semisolid media. For
this purpose, a
Y. pestis strain constitutively expressing GFP,
EV76(pGFPuv), was constructed. The bacteria were grown in agar-containing
microplate wells and incubated in a fluorescence plate reader.
A direct correlation between the fluorescence level and bacterial
cell mass was found by quantifying both the fluorescence and
the CFU present in bacterial suspensions prepared from these
agar cultures, as demonstrated in Fig.
1. This correlation allowed
the determination of the growth rate on agar by monitoring (hourly)
the fluorescence emitted by the bacterial culture in situ during
incubation. Fluorescence-derived growth curves on BHIA were
used as the reference for optimal growth rate. As shown in Fig.
1, the growth rate on CIN and MacConkey agars is lower than
that on BHIA. Thus, low recoverability of
Y. pestis on these
media, as shown by colony formation efficiency, was manifested
also by the slow accumulation of cell mass during incubation,
using monitoring of fluorescence emitted by growing bacteria
(Fig.
1). Furthermore, this type of evaluation showed that the
basal CIN formulation is less growth supportive than the BHIA.
For this reason, BHIA was chosen as the basal medium for the
formulation of an optimized combination of selective agents
that would support high recoverability of
Y. pestis. The growth
inhibition effect of various selective agents was quantified
by introducing them individually into BHIA at several concentrations,
and the growth rates on the different agar formulations were
monitored by using the GFP reporter. This strategy allowed the
determination of the maximal levels of irgasan (1 µg/ml),
crystal violet (0.5 µg/ml), and bile salts (sodium cholate
and sodium deoxycholate, 500 µg/ml each) that are tolerated
by EV76 with no inhibition effect on the growth rate (Fig.
2).
Both cefsulodin and novobiocin were clearly harmful and hampered
growth at the concentrations routinely used in CIN agar (4 and
2.5 µg/ml, respectively). As expected, the mycobacterial
agent nystatin showed no effect on growth of the reporter strain.
Selective-agent combinatorial experiments, analyzed by both
plating efficiency and monitoring of agar culture GFP-mediated
fluorescence assays, resulted in the formulation of the BIN
medium described in Table
2. The growth rate of the GFP-expressing
EV76 strain on BIN agar was found to be only slightly lower
than that on BHIA (Fig.
3). The newly developed BIN selective
medium contains cholate salts at a concentration similar to
that in CIN agar and contains crystal violet at a concentration
similar to those in both CIN and MacConkey agars. However, the
level of irgasan is fivefold lower than that in CIN agar, and
the formulation is based on the nondefined rich BHIA as the
basal medium. The antibacterial agents cefsulodin and novobiocin
were omitted, since they were found to be inhibitory to
Y. pestis at the concentrations routinely used in CIN agar. No attempt
was made to include them at reduced concentrations in the final
medium, as such a reduction is expected to allow growth of some
competitor organisms. The mycobacterial agent nystatin has a
wide spectrum of antifungal activity, yet it has no activity
against bacteria (
15). Therefore, it was included in the BIN
medium to increase the potential for isolation of
Y. pestis from environmental samples.
The growth of different
Y. pestis strains on the BIN medium
was compared to that on commercial selective media. All strains
were recovered more efficiently on BIN medium than on CIN or
MacConkey medium (Table
3). The virulent strain (Kimberley53)
had three- to sixfold-higher CFU counts on BIN medium, and the
nonvirulent strains exhibited differences in the recoverability
on the various media. Generally, BIN medium provided higher
recovery values, up to 25-fold over CIN medium and more than
1,000-fold over MacConkey medium, as summarized in Table
3.
Our results indicate that
Y. pestis strains may exhibit variable
tolerance toward different selective agents.
Y. pestis colonies
developing on the gray background of BIN medium exhibited a
typical light bluish shade in the center and a transparent precipitate
in the surrounding area. The bluish-gray center was noticed
in colonies of all
Yersinia strains tested and became more pronounced
after further incubation at 4°C.
Selectivity of BIN medium.
The lack of antimicrobial agents in the BIN medium could result
in reduced selectivity to other competitive organisms. A limited
characterization of the BIN selectivity profile was conducted
with several gram-positive and gram-negative bacteria which
represent both clinically important strains and strains commonly
found in the open environment. BIN medium was found to be completely
inhibitory to gram-positive bacteria, yet its selectivity toward
gram-negative bacteria was only partial, as summarized in Table
4. In this aspect BIN agar was found to be more selective than
MacConkey agar, which allowed the growth of all tested gram-negative
strains, but less selective than CIN agar. Nevertheless, all
non-
Yersinia strains tested were easily differentiated from
the slow-developing
Y. pestis colonies, either by growth rate
or by morphological characteristics. White
V. cholerae, yellow-green
P. aeruginosa, and red-pigmented
S. marcescens colonies could
be observed already after 1 day, whereas gray
Y. pestis colonies
of

2 mm in diameter require 2 days to develop. On the other
hand,
E. faecalis growth on BIN agar was very slow, and colony
diameters were less then 0.5 mm after 3 days of incubation.
Recovery from dead mice.
The effective selectivity of BIN agar together with its ability
to support growth of
Y. pestis at favorable recovery yields
prompted us to test its potential advantage in isolation of
Y. pestis from samples consisting of mixed bacterial population
under metabolic stress, such as decomposing carcasses (a model
of environmental plague in dead rodents). Twenty mice were inoculated
subcutaneously with 100 LD
50 of the virulent strain
Y. pestis Kimberley53. After death, decaying carcasses were kept separately
at ambient temperature for 3, 5, 8, and 11 days before isolation
of
Y. pestis was attempted. Isolation of
Y. pestis after 1 day
was not attempted, since it has been previously established
that >10
8 Y. pestis bacteria and >10
10 other contaminating
organisms are present at this stage (
16). The attempts to isolate
Y. pestis from samples prepared from spleen homogenates are
summarized in Table
5. For all samples, attempts of plating
homogenate dilutions or isolation by streaking on rich media
(BHIA and blood agar) resulted, after 1 day of incubation, in
high CFU counts of fast-growing non-
Yersinia bacteria, which
completely prevented the identification of the slow-developing
Y. pestis colonies. Similarly, plating on MacConkey agar revealed
high numbers of both lactose-positive and lactose-negative colonies,
many of which exhibited high growth rates that resulted in coverage
of the agar surface long before
Y. pestis colonies began to
appear. The only media that allowed direct and efficient isolation
of
Y. pestis colonies were the selective CIN and BIN media.
Background levels of other contaminating organisms on both media
were negligible, with CIN agar exhibiting better selectivity
but lower recoverability. A continuous decline in
Y. pestis CFU/spleen (on both CIN and BIN agars) was observed over the
period of about 10 days after the animal succumbed, while background
bacteria counts remained high at this time as determined by
plating on nonselective blood agar and BHIA or on MacConkey
agar. As long as
Y. pestis counts were above

10
6 CFU/spleen,
the recovery on BIN agar was about twofold higher than that
on CIN agar. However, as
Y. pestis counts in the decomposing
tissues declined (probably due to severe metabolic stress or
competition conditions), the advantage of BIN agar became more
pronounced, as the BIN/CIN ratio increased to about fourfold
(Table
5). Similar results were obtained with samples taken
from livers of the same mice. These results clearly emphasize
the advantageous growth-supportive characteristic of BIN agar.
Furthermore, similar results were obtained with
Y. enterocolitica bacteria recovered from dead mice following oral infection with
lethal doses of
Y. enterocolitica. The recoverability of
Y. enterocolitica from spleens of dead mice 5 days postmortem was
three- to sixfold higher on BIN agar than on CIN agar (data
not shown), indicating the advantage of BIN agar for isolation
of probably all clinically important
Yersinia strains from an
environment imposing metabolic stress.
In summary, the BIN medium is superior to the WHO-recommended
selective medium, MacConkey medium, as well as to the commercial
CIN medium for isolation and recovery of
Y. pestis from pure
and fresh samples as well as from background environments where
the bacterium is expected to be under stress.

FOOTNOTES
* Corresponding author. Mailing address: Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 74100, Israel. Phone: 972-8-9381718. Fax: 972-8-9401404. E-mail:
cohens{at}iibr.gov.il.


REFERENCES
1 - Aleksic, S., and J. Bockemuhl. 1999. Yersinia and other Enterobacteriaceae, p. 483-496. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. American Society for Microbiology, Washington, D.C.
2 - Ben-Gurion, R., and I. Hertman. 1958. Bacteriocin-like material produced by Pasteurella pestis. J. Gen. Microbiol. 19:289-297.[Abstract/Free Full Text]
3 - Brubaker, R. R. 1991. Factors promoting acute and chronic disease caused by Yersiniae. Clin. Microbiol. Rev. 4:309-324.[Abstract/Free Full Text]
4 - Butler, T. 2000. Yersinia species, including plague, p. 2406-2414. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 5th ed. Churchill Livingstone, Philadelphia, Pa.
5 - Campbell, G. L., and D. T. Dennis. 1998. Plague and other Yersinia infections, p. 975-983. In A. S. Fauci, E. Braunwald, K. J. Isselbacher, J. D. Wilson, J. B. Martin, D. L. Kasper, S. L. Hauser, and D. L. Longo (ed.), Harrison's principles of internal medicine. McGraw Hill, New York, N.Y.
6 - Chanteau, S., L. Rhalison, L. Ralafiarisoa, J. Foulon, M. Ratsitorahina, L. Ratsifasoamanana, E. Carniel, and F. Nato. 2003. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet 361:211-216.[CrossRef][Medline]
7 - Christie, A. B. 1982. Plague: review of ecology. Ecol. Dis. 1:111-115.[Medline]
8 - Cohen, S., I. Mendelson, Z. Altboum, D. Kobiler, E. Elhanani Y, T. Bino, M. Leitner, I. Inbar, H. Rosenberg, Y. Gozes, R. Barak, M. Fisher, C. Kronman, B. Velan, and A. Shafferman. 2000. Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax. Infect. Immun. 68:4549-4558.[Abstract/Free Full Text]
9 - Conchas, R. F., and E. Carniel. 1990. A highly efficient electroporation system for transformation of Yersinia. Gene 87:133-137.[CrossRef][Medline]
10 - Dennis, D. T., K. L. Gage, N. Gratz, J. D. Poland, and E. Tikhomriov. 1999. Plague manual: epidemiology, distribution, surveillance and control. World Health Organization, Geneva, Switzerland.
11 - Drennan, J. G., and O. Teague. 1917. Selective medium for the isolation of B. pestis from contaminated plague lesions and observations on the growth of B. pestis on autoclaved agar. J. Med. Res. 36:519-524.
12 - Gage, K. L., D. T. Dennis, K. A. Orloski, P. Ettestad, T. L. Brown, P. J. Reynolds, W. J. Pape, C. L. Fritz, L. G. Carter, and J. D. Stein. 2000. Cases of cat-associated human plague in the Western US, 1977-1998. Clin. Infect. Dis. 30:893-900.[CrossRef][Medline]
13 - Grosfeld, H., S. Cohen, T. Bino, Y. Flashner, R. Ber, E. Mamroud, C. Kronman, A. Shafferman, and B. Velan. 2003. Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen. Infect. Immun. 71:374-383.[Abstract/Free Full Text]
14 - Inglesby, T. V., D. T. Dennis, D. A. Henderson, J. G. Bartlett, M. S. Ascher, E. Eitzen, A. D. Fine, A. M. Friedlander, J. Hauer, J. F. Koerner, M. Layton, J. McDade, M. T. Osterholm, T. O'Toole, G. Parker, T. M. Perl, P. K. Russell, M. Schoch-Spana, K. Tonat, et al. 2000. Plague as a biological weapon: medical and public health management. JAMA 283:2281-2290.[Abstract/Free Full Text]
15 - Kucers, A., S. M. Crowe, M. L. Grayson, and J. F. Hoy. 1997. The use of antibiotics: a clinical review of antibacterial, antifungal and antiviral drugs, p. 1295-1300. Butterworth-Heinemann, Oxford, United Kingdom.
16 - Markenson, J., R. Ben Gurion, and S. Ben Efraim. 1971. Une nouvelle methode pour le diagnostic rapide de la peste chez les rongeurs morts. Ann. Inst. Pasteur 121:183-185.[Medline]
17 - Markenson, J., and S. Ben-Efraim. 1963. Oxgall medium for identification of Pasteurella pestis. J. Bacteriol. 85:1443-1445.[Free Full Text]
18 - Meyer, K. F., and A. P. Batchelder. 1926. Selective mediums in the diagnosis of rodent plague. J. Infect. Dis. 39:370-385.
19 - Morris, E. J. 1958. Selective media for some Pasteurella species. J. Gen. Microbiol. 19:305-311.
20 - Perry, R. D., and J. D. Fetherston. 1997. Yersinia pestis: etiologic agent of plague. Clin. Microbiol. Rev. 10:35-66.[Abstract]
21 - Politzer, R. 1954. Plague. WHO Monogr. Ser. 22:1.
22 - Rasoamanana, B., L. Rahalison, C. Raharimanana, and S. Chanteau. 1996. Comparison of Yersinia CIN agar and mouse inoculation assay for the diagnosis of plague. Trans. R. Soc. Trop. Med. Hyg. 90:651.[CrossRef][Medline]
23 - Russell, P., M. Nelson, D. Whittington, M. Green, S. M. Eley, and R. W. Titball. 1997. Laboratory diagnosis of plague. Br. J. Bio. Sci. 54:231-236.
24 - Schiemann, D. A. 1979. Synthesis of a selective agar medium for Yersinia enterocolitica. Can. J. Microbiol. 25:1298-1304.[Medline]
25 - Thal, E., and T. H. Chen. 1955. Two simple tests for the differentiation of plague and pseudotuberculosis bacilli. J. Bacteriol. 69:103-104.[Free Full Text]
26 - World Health Organization. 2000. Human plague in 1998 and 1999. Wkly. Epidemiol. Rec. 75:338-343.[Medline]
27 - World Health Organization. 1970. W. H. O. Expert Committee on Plague. Fourth Report. WHO Tech. Rep. Ser. 447:1-25.
28 - Wu, X.-C., W. Lee, L. Tran, and S. L. Wong. 1991. Engineering a Bacillus subtilis expression-secretion system with a strain deficient in six extracellular proteases. J. Bacteriol. 173:4952-4958.[Abstract/Free Full Text]
Applied and Environmental Microbiology, October 2003, p. 5787-5792, Vol. 69, No. 10
0099-2240/03/$08.00+0 DOI: 10.1128/AEM.69.10.5787-5792.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Velan, B., Bar-Haim, E., Zauberman, A., Mamroud, E., Shafferman, A., Cohen, S.
(2006). Discordance in the Effects of Yersinia pestis on the Dendritic Cell Functions Manifested by Induction of Maturation and Paralysis of Migration. Infect. Immun.
74: 6365-6376
[Abstract]
[Full Text]
-
Zauberman, A., Cohen, S., Mamroud, E., Flashner, Y., Tidhar, A., Ber, R., Elhanany, E., Shafferman, A., Velan, B.
(2006). Interaction of Yersinia pestis with Macrophages: Limitations in YopJ-Dependent Apoptosis.. Infect. Immun.
74: 3239-3250
[Abstract]
[Full Text]
-
Flashner, Y., Mamroud, E., Tidhar, A., Ber, R., Aftalion, M., Gur, D., Lazar, S., Zvi, A., Bino, T., Ariel, N., Velan, B., Shafferman, A., Cohen, S.
(2004). Generation of Yersinia pestis Attenuated Strains by Signature-Tagged Mutagenesis in Search of Novel Vaccine Candidates. Infect. Immun.
72: 908-915
[Abstract]
[Full Text]